Deutsche Bank cuts its Novartis rating to Sell from Hold
Deutsche Bank has lowered its recommendation on Swiss Novartis shares to Sell from Hold, per TradingView citing Benzinga data today.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Deutsche Bank has lowered its rating on Novartis to Sell from Hold, according to a report published by TradingView. The item also points to Benzinga reference data, which contains price targets and the full history of analyst recommendations for the stock.
why it matters
An analyst downgrade to Sell signals that a major bank sees limited upside in the Swiss drugmaker's shares. Such calls are routine, but they can weigh on sentiment toward the stock in the short term, especially among investors tracking pharma sector ratings.
tags
instruments
sources
- Deutsche Bank downgrades Novartis to Sell from Hold — TradingView, 30 October 2026 at 16:58 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗